TADA2B is a subunit of the chromatin-modifying SAGA complex that links histone modification to stem cell maintenance, lineage commitment, and genome stability (PMID:34711655, PMID:41577693). Within SAGA's histone acetyltransferase module, TADA2B supports deposition of histone H3 lysine 9 acetylation (H3K9ac) and influences H2B ubiquitination (H2Bub) enrichment; in hematopoietic stem and progenitor cells, its loss reduces H3K9ac, alters H2Bub, blocks hematopoiesis with accumulation of immature bone marrow cells, lowers mitochondrial activity, skews toward megakaryocyte progenitor commitment, and activates interferon pathway gene expression (PMID:41577693). Beyond its chromatin role, TADA2B constitutively binds the DNA single-strand break repair scaffold XRCC1 through its BRCT II domain, independent of DNA damage status and of GCN5 acetyltransferase activity, and TADA2B depletion impairs XRCC1 recruitment to damage sites; an SCAR26-associated XRCC1 variant selectively disrupts this TADA2B interaction while preserving LIG3 binding [PMID:bio_10.1101_2025.08.24.672030]. In human embryonic stem cells, TADA2B is a central regulator of pluripotency maintenance, survival, growth, and three-germ-layer lineage specification (PMID:34711655).